USPTO trademark

NEXURBY

AllowedUSPTOWord markClass 5

"NEXURBY" is a word mark owned by AstraZeneca Ireland Limited, filed at the USPTO on November 10, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View AstraZeneca Ireland Limited portfolioGet this data via the API
Official USPTO record
NEXURBY trademark as filed
As filed with the USPTO
Status
Allowed
Since April 28, 2026
Filed
November 10, 2025
Registered
Not yet
Priority date
May 8, 2025
Claimed from European Union
Application no.
99488670
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns NEXURBY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca Ireland Limited

Dublin 15, Ireland

68 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services NEXURBY is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for use in oncology; Vaccines; Antibodies for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Teas delete 1(b) basis received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Assigned to examiner

3 earlier steps on the official record.

FAQ

About NEXURBY

Who owns the trademark "NEXURBY"?

The USPTO trademark "NEXURBY" (application 99488670) is owned by AstraZeneca Ireland Limited.

What is the status of "NEXURBY"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NEXURBY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b5a-10f4-74d9-acdb-bc8089b39874
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b5a-10f4-74d9-acdb-bc8089b39874",
  "object": "trademark",
  "mark_text": "NEXURBY",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99488670",
  "filing_date": "2025-11-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca Ireland Limited",
      "entity_id": "ent_019eb7d2-439b-768c-9359-8ae13a3713f9"
    }
  ]
}